HCA Latest Quarter's Earnings
| Announce Date | 01/27/2026 |
| EPS Normalized Actual | $8.01 (Beat by $0.55) |
| EPS GAAP Actual | $8.01 (Beat by $0.55) |
| Revenue Actual | $19.513B |
| Revenue Surprise | Beat by $19513M |
Upcoming Quarter's Earnings
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $5.8933 |
| EPS GAAP Estimate | $5.8933 |
| Revenue Estimate | $18.539224993B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 45.94 | 10.83 | 44.95419 | 46.82039 | 5 |
| Dec 2029 | 0 | INF | 0 | 0 | 5 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 8.14 | 2.88224 | 19.513B | 6.29% | 1404.42M |
| FQ3 2025 (Sep 2025) | -13.44 | -13.44 | 19.161B | 8.74% | 19161M |
| FQ2 2025 (Jun 2025) | 0.0283 | 0.0283 | 18.605B | 5.98% | 18605M |
| FQ1 2025 (Mar 2025) | 6.45 | 6.45 | 18.321B | 5.36% | 18321M |
| FQ4 2024 (Dec 2024) | 5.63 | 5.63 | 18.285B | 5.37% | 18285M |
| FQ3 2024 (Sep 2024) | -11.5 | -11.5 | 17.487B | 7.29% | 17487M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 17.492B | 9.32% | 17492M |
| FQ1 2024 (Mar 2024) | 5.93 | 5.93 | 17.339B | 10.08% | 17339M |
Quarterly Estimates Summary
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
5.8933
Consensus Revenue Estimates
18.539224993B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 7.99 | -- | 7.86964 | 8.13236 | 7 |
| FQ2 2028 (Jun 2028) | 9.21 | -- | 9.07126 | 9.3741 | 6 |
| FQ1 2028 (Mar 2028) | 8.6 | -- | 8.47045 | 8.75323 | 6 |
| FQ4 2027 (Dec 2027) | 8.77 | -- | 8.61917 | 8.90532 | 8 |
| FQ3 2027 (Sep 2027) | 7 | -- | 6.87961 | 7.10801 | 8 |
| FQ2 2027 (Jun 2027) | 7.42 | -- | 7.29238 | 7.53449 | 8 |
| FQ1 2027 (Mar 2027) | 7.26 | -- | 7.13514 | 7.37202 | 8 |
| FQ4 2026 (Oct 2026) | 5.91422 | -37.63 | 5.82282 | 6.04434 | 3 |
| FQ3 2026 (Jul 2026) | 6.01838 | 323.32 | 5.92537 | 6.15079 | 5 |
| FQ2 2026 (Jun 2026) | 6.12172 | 99.54 | 5.98359 | 6.26303 | 9 |
| FQ1 2026 (Mar 2026) | 5.8933 | -9.45 | 5.76032 | 6.02933 | 9 |
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 21.72B | -- | 21.47B | 22.01B | 5 |
| FQ2 2028 (Jun 2028) | 21.33B | -- | 21.08B | 21.62B | 5 |
| FQ1 2028 (Mar 2028) | 20.96B | -- | 20.71B | 21.24B | 6 |
| FQ4 2027 (Dec 2027) | 21.35B | -- | 21.07B | 21.6B | 9 |
| FQ3 2027 (Sep 2027) | 20.67B | -- | 20.39B | 20.91B | 9 |
| FQ2 2027 (Jun 2027) | 20.52B | -- | 20.25B | 20.76B | 9 |
| FQ1 2027 (Mar 2027) | 20.31B | -- | 20.04B | 20.55B | 9 |
| FQ4 2026 (Oct 2026) | 19.2B | -1.64 | 18.97B | 19.52B | 4 |
| FQ3 2026 (Jul 2026) | 19.14B | -0.09 | 18.92B | 19.47B | 6 |
| FQ2 2026 (Jun 2026) | 19.01B | 2.12 | 18.68B | 19.35B | 6 |
| FQ1 2026 (Mar 2026) | 18.54B | 1.18 | 18.22B | 18.87B | 12 |
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 5.25776 | 8.14 | 2.88224 | 35.41% |
| FQ3 2025 (Sep 2025) | -13.44 | -13.44 | 100% | |
| FQ2 2025 (Jun 2025) | 0.0283 | 0.0283 | 100% | |
| FQ1 2025 (Mar 2025) | 6.45 | 6.45 | 100% | |
| FQ4 2024 (Dec 2024) | 5.63 | 5.63 | 100% | |
| FQ3 2024 (Sep 2024) | -11.5 | -11.5 | 100% | |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 5.93 | 5.93 | 100% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $18.11B | $19.51B | $1404.42M | 7.2% |
| FQ3 2025 (Sep 2025) | $0B | $19.16B | $19161M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $18.61B | $18605M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $18.32B | $18321M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $18.29B | $18285M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $17.49B | $17487M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $17.49B | $17492M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $17.34B | $17339M | 100% |
HCA Ratings Summary
HCA Quant Ranking
